首页> 外文期刊>Journal of clinical apheresis. >Prospective, randomized, sequential, crossover trial of large-volume vs. normal-volume leukapheresis procedures: effects on subpopulations of CD34(+) cells.
【24h】

Prospective, randomized, sequential, crossover trial of large-volume vs. normal-volume leukapheresis procedures: effects on subpopulations of CD34(+) cells.

机译:大容量与正常体积白血病手术的前瞻性,随机,顺序,交叉试验:对CD34(+)细胞亚群的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Some data exist on the influence of leukapheresis volume on the number of harvested peripheral blood hematopoietic progenitor cells (HPC), but less is known about the influence on the composition of HPC. We therefore performed a prospective, randomized crossover trial to evaluate the effect of large-volume (LVL) vs. normal-volume leukapheresis (NVL) on subpopulations of CD34(+) cells in the harvest product of 15 patients with breast cancer and 8 patients with non-Hodgkin's lymphoma. Patients were randomly assigned to start either with an LVL on day 1 followed by an NVL on day 2 or vice versa. The number of HPC, the extraction efficiency defined as difference between yield in the harvest and decrease in peripheral blood, and the relative proportion as well as the absolute numbers of CD34(+) cells coexpressing CD38, CD90, HLA-DR, CD117, CD7, CD19, CD41, or CD33 were evaluated. There was no significant difference with regard to the percentages of the subsets on comparison of LVL to NVL procedures. Only the absolute median number of CD34(+)HLA-DR(-) cells was significantly (P=0.02) higher in LVL harvests compared with the corresponding NVL components, which can be explained on the basis of the higher yield and the higher extraction efficiency in LVL compared with NVL. LVL results in a higher yield of CD34(+) cells and leads to an intra-apheresis recruitment of HPC but the relative composition of the harvested CD34(+) cells is not changed significantly. In addition, the amount of early, HLA-DR(-), hematopoietic HPC seems to be increased by an LVL.
机译:存在一些数据存在于白血病体积对收获的外周血造血祖细胞(HPC)的数量的影响,但对HPC组成的影响较小。因此,我们进行了前瞻性随机的交叉试验,以评估大体积(LVL)与正常体积白蛋白酶(NVL)对乳腺癌和8名患者的15例患者的收获产物中CD34(+)细胞群的影响用非霍奇金的淋巴瘤。随机分配患者在第1天用LVL进行一次,然后在第2天,反之亦然。 HPC的数量,提取效率定义为收获产量与外周血下降的差异,以及相对比例以及CD34(+)细胞的绝对数量,CD38,CD90,HLA-DR,CD117,CD7评估CD19,CD41或CD33。关于与NVL程序比较的子集的百分比没有显着差异。与相应的NVL组分相比,在LVL收获中,只有明显的CD34(+)HLA-DR( - )细胞的绝对中值数量显着(p = 0.02),这可以基于更高的产量和更高的提取来解释与NVL相比LVL的效率。 LV1导致CD34(+)细胞的产率更高,并导致HPC的内部植物内募集,但收获的CD34(+)细胞的相对组成不会显着变化。此外,早期的HLA-DR( - ),造血HPC似乎通过LVL增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号